Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nozomi Yashima"'
Autor:
Takaaki Totoki, Takashi Ito, Midori Kakuuchi, Nozomi Yashima, Ikuro Maruyama, Yasuyuki Kakihana
Publikováno v:
Thrombosis Journal, Vol 20, Iss 1, Pp 1-5 (2022)
Abstract Background Administration of recombinant human soluble thrombomodulin (rTM) is often used in Japan to treat septic disseminated intravascular coagulation (DIC). Thrombin-activatable fibrinolysis inhibitor (TAFI) is a fibrinolysis inhibitor a
Externí odkaz:
https://doaj.org/article/bd2206a6bbb041968c43447f08d1634f
Autor:
Takuro Arishima, Takashi Ito, Tomotsugu Yasuda, Nozomi Yashima, Hiroaki Furubeppu, Chinatsu Kamikokuryo, Takahiro Futatsuki, Yutaro Madokoro, Shotaro Miyamoto, Tomohiro Eguchi, Hiroyuki Haraura, Ikuro Maruyama, Yasuyuki Kakihana
Publikováno v:
Thrombosis Journal, Vol 16, Iss 1, Pp 1-7 (2018)
Abstract Background Recombinant human soluble thrombomodulin (rTM) has been used for the treatment of disseminated intravascular coagulation in Japan, and an international phase III clinical trial for rTM is currently in progress. rTM mainly exerts i
Externí odkaz:
https://doaj.org/article/da843b2c0fd24c6f91b2e21f13318f91
Autor:
Takaaki Totoki, Takashi Ito, Midori Kakuuchi, Nozomi Yashima, Ikuro Maruyama, Yasuyuki Kakihana
Publikováno v:
Thrombosis Journal, Vol 20, Iss 1, Pp 1-5 (2022)
Background Administration of recombinant human soluble thrombomodulin (rTM) is often used in Japan to treat septic disseminated intravascular coagulation (DIC). Thrombin-activatable fibrinolysis inhibitor (TAFI) is a fibrinolysis inhibitor activated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fbab2272955db9e21576e4d39d750dd
https://pubmed.ncbi.nlm.nih.gov/35130927
https://pubmed.ncbi.nlm.nih.gov/35130927
Autor:
Takaaki Totoki, Takashi Ito, Midori Kakuuchi, Nozomi Yashima, Ikuro Maruyama, Yasuyuki Kakihana
Background: Administration of recombinant human soluble thrombomodulin (rTM) is often used in Japan to treat septic disseminated intravascular coagulation (DIC). Thrombin-activatable fibrinolysis inhibitor (TAFI) is a fibrinolysis inhibitor activated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cff2d41f34c7b38262fa020e561f6e57
https://doi.org/10.21203/rs.3.rs-37394/v1
https://doi.org/10.21203/rs.3.rs-37394/v1
Autor:
Tomotsugu Yasuda, Ikuro Maruyama, Tomohiro Eguchi, Yutaro Madokoro, Yasuyuki Kakihana, Takahiro Futatsuki, Shotaro Miyamoto, Hiroyuki Haraura, Nozomi Yashima, Hiroaki Furubeppu, Takashi Ito, Chinatsu Kamikokuryo, Takuro Arishima
Publikováno v:
Thrombosis Journal, Vol 16, Iss 1, Pp 1-7 (2018)
Thrombosis Journal
Thrombosis Journal
Background Recombinant human soluble thrombomodulin (rTM) has been used for the treatment of disseminated intravascular coagulation in Japan, and an international phase III clinical trial for rTM is currently in progress. rTM mainly exerts its antico
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe881903b7ac9ffd7fc135bea13624f5
http://link.springer.com/article/10.1186/s12959-018-0178-0
http://link.springer.com/article/10.1186/s12959-018-0178-0
Autor:
Shinya Oda, Kaneyuki Kawamae, Nozomi Yashima, Kei Otaki, Hutaba Kurihara, Misato Kurota, Airi Kumasaka, Sachiko Matsushita
Publikováno v:
Journal of Anesthesia. 30:653-662
Noninvasive positive pressure ventilation (NPPV) using a helmet is expected to cause inspiratory trigger delay due to the large collapsible and compliant chamber. We compared the work of breathing (WOB) of NPPV using a helmet or a full face-mask with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0197c8a7654c3e75f5c4d6cde052d256
https://doi.org/10.1007/s00540-016-2168-3
https://doi.org/10.1007/s00540-016-2168-3